# Technion - Israel Institute of Technology

> Technion - Israel Institute of Technology is a VC fund backing Medical. See 5 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Haifa, Israel
- Total investments: 5
- Last investment: Nov 2025
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/edu/technion---israel-institute-of-technology-13396
- X (Twitter): http://twitter.com/TechnionLive
- Website: https://www.technion.ac.il/
- Facebook: http://www.facebook.com/Technion.International.School

Technion - Israel Institute of Technology is a VC fund in Haifa focused on Medical and Health Care. “Technikum” - the original German name of the Technion - is a tale of the century. The second industrial revolution created the printing presses and communications infrastructure allowing Jews scattered across the globe to organize in face of rising anti-Semitism. As Jews were often barred from technical education, the establishment of a technicalschool was a first priority to rebuilding a Jewish homeland. The Technion was to become unique worldwide as a university that would precede, create, shape, and protect a modern state.The cornerstone laid on April 11, 1912, set in motion a century of progress responding to national and global needs. Technion would grow rapidly, becoming a global pioneer in fields such as biotechnology, stem cells, space, computer science, nanotechnology, and energy. Three Technion professors have won Nobel Prizes. As it celebrates its cornerstone centennial in 2012, Technion City is a thriving world center of research and teaching, with 12,850 students and 80 graduate programs trailblazing excellence in research and teaching for the benefit of humanity.

## Contacts

5 contacts available for Technion - Israel Institute of Technology. Shizune tracks 15 team members at Technion - Israel Institute of Technology. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/technion-israel-institute-of-technology?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $2.2M–$20M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 3 | 60% |
| Health Care | 3 | 60% |
| Therapeutics | 2 | 40% |
| Biotechnology | 2 | 40% |
| Drones | 1 | 20% |

15 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 3 | 60% |
| Series B | 1 | 20% |
| Venture - Series Unknown | 1 | 20% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Israel | 4 | 80% |
| United States | 1 | 20% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Albert Einstein | Founder | 0 | https://shizune.co/investors/profile/albert-einstein-732a |
| Amichai Shulman | Adjunct Teacher | 6 | https://shizune.co/investors/profile/amichai-shulman |
| Carmel Rotschild | Senior Lecturer | 0 | https://shizune.co/investors/profile/carmel-rotschild |
| Eyal S. Ron | Mentor | 0 | https://shizune.co/investors/profile/eyal-s-ron |
| Guy Yachdav | Lecturer on Machine Learning | 0 | https://shizune.co/investors/profile/guy-yachdav |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Levron Medical | Levron Medical develops a novel autonomic integrated diagnostic and therapeutic device used to treat heart failure patients. | $2.2M | Seed | Nov 24, 2025 |  |
| Mana.bio | Mana.bio develops artificial intelligence–based platforms for drug delivery using lipid nanoparticles (LNPs). The company combines machine learning with nanotechnology to design, test, and refine LNP formulations through computational modeling and laboratory validation. Its technology focuses on extrahepatic tissue targeting and includes researchon lung-targeted delivery and safety improvements through predictive modeling. Mana.bio has introduced ChatLNP, a tool that supports literature analysis, property prediction, and formulation optimization. The platform integrates experimental results with public data to enhance model accuracy and broaden its design capabilities for gene therapy and RNA-based medicines. | $19.5M | Seed | Oct 10, 2023 |  |
| ViAqua Therapeutics | ViAqua Therapeutics Ltd develops drugs and therapeutics for aquaculture. The company was founded in 2014 and is based in Israel.ViAqua Therapeutics is developing the first orally administered treatment for aquaculture.The Company’s management bring a broad range of business development, technology development, management, and industrial biotechexperience. | $4.3M | Venture - Series Unknown | Jun 09, 2021 |  |
| Lydus Medical | Lydus Medical is a start-up company that develops a set of tools for anastomosis of small blood vessels. The company was founded in 2017 and is headquartered in Kfar Saba, Israel. | $2.7M | Seed | May 24, 2021 |  |
| Regulus Cyber | Regulus provides affordable GNSS spoofing detection and protection to the mass markets requiring reliability and low-cost. The Pyramid Software technology defends against ever-increasing attacks and interferences.The Regulus Pyramid GNSS technology provides revolutionary tools to defend against GNSS/GPS spoofing attacks for automotive,mobile, maritime, aviation, critical infrastructure and various other applications, markets and users. *(GNSS = Global Navigation Satellite Systems: GPS, BeiDou, Galileo, Glonass, and more.) | $4M | Series B | May 18, 2020 |  |

5 of 5 investments shown.

## Co-investors
- [S2G Investments](https://shizune.co/investors/profile/s2g-ventures) — VC Fund, 2 deals together
- [Agriline](https://shizune.co/investors/profile/agriline) — VC Fund, 1 deal together
- [Alon Medtech Ventures](https://shizune.co/investors/profile/alon-medtech-ventures) — VC Fund, 1 deal together
- [Andreessen Horowitz](https://shizune.co/investors/profile/andreessen-horowitz) — VC Fund, 1 deal together
- [Base4 Capital](https://shizune.co/investors/profile/base4-capital) — VC Fund, 1 deal together
- [b2venture](https://shizune.co/investors/profile/btovpartners) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [OurCrowd](https://shizune.co/investors/profile/ourcrowd) — VC Fund
- [Entrée Capital](https://shizune.co/investors/profile/entree-capital) — VC Fund
- [Pitango VC](https://shizune.co/investors/profile/pitango-venture-capital) — VC Fund

## Featured in investor lists
- [Medical Investors in Middle East](https://shizune.co/investors/medical-investors-middle-east)
- [Medical VC Funds in Middle East](https://shizune.co/investors/medical-vc-funds-middle-east)
- [Medical Investors in Israel](https://shizune.co/investors/medical-investors-israel)
- [Medical VC Funds in Israel](https://shizune.co/investors/medical-vc-funds-israel)

## FAQ

### What does Technion - Israel Institute of Technology invest in?

Technion - Israel Institute of Technology invests primarily in Medical, Health Care and Therapeutics startups, most often at Seed and Series B stage. Most of the 5 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Technion - Israel Institute of Technology's check size?

Technion - Israel Institute of Technology typically joins rounds of $2.2M–$20M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Technion - Israel Institute of Technology participates in.

### How do I contact Technion - Israel Institute of Technology?

Public channels for Technion - Israel Institute of Technology include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Technion - Israel Institute of Technology?

The team at Technion - Israel Institute of Technology includes Albert Einstein (Founder), Amichai Shulman (Adjunct Teacher) and Carmel Rotschild (Senior Lecturer), among 15 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co